VAERS Explorer
Back to explore

Report #2826037

Received Feb 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Myalgia

Symptom narrative

muscle ache after administering Arexvy; This non-serious case was reported by a physician via sales rep and described the occurrence of muscle pain in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced muscle pain (Verbatim: muscle ache after administering Arexvy). The outcome of the muscle pain was not reported. It was unknown if the reporter considered the muscle pain to be related to Arexvy. It was unknown if the company considered the muscle pain to be related to Arexvy. Additional Information: GSK Receipt Date: 04-DEC-2024 The physician reported that a patient received Arexvy vaccine and experienced muscle pain. The doctor got Arexvy vaccine and that said similar adverse event to Shingrix muscle aches. She said checks/makes sure patient get vaccines wants her to have health care professional guide. The doctor had patient who was copay too high on Arexvy. Gave co-pay card and she was going to call patient to came get it.